Bigul

Neogen Chemicals Ltd - 542665 - Board Meeting Outcome for Intimation Of Technology License Agreement

With regards to the captioned subject and in compliance with the Listing Regulations, we wish to inform you that the Board of Directors of Neogen Chemicals Limited ('Neogen') has at its meeting held today i.e. Monday, April 10, 2023 which commenced at 2.30 p.m. (IST) and concluded at 3.22 p.m.(IST), inter alia, considered and approved the execution of an agreement with MU Ionic Solutions Corporation ('MUIS'), Japan (a JV between Mitsubishi Chemical Corporation (MCC) and UBE Corporation and is a group company of The Mitsubishi Chemical Group (the group) a Japanese conglomerate) ('the Agreement'), to acquire manufacturing technology license for electrolytes in India subject to the terms and conditions as mentioned in the Agreement ('Transaction'). The details required under regulation 30 of the Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD /4/2015 dated September 9, 2015 is attached herewith.
10-04-2023
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Listing Regulations, we would like to inform you that the management of Neogen Chemicals Limited will be participating in a conference call Today, Monday, April 10, 2023 at 5.30 p.m. IST for analysts and investors, to discuss business update. The Invite for the said call is enclosed herewith for your reference.
10-04-2023

Neogen Chemicals up 7% on reports of partnership with Japanese major

Neogen Chemicals will announce a technology transfer arrangement with a major Japanese conglomerate which reportedly will involve manufacturing of lithium electrodes under the government's product-linked incentive (PLI) scheme
10-04-2023
Bigul

Neogen Chemicals Ltd - 542665 - Compliance Certificate For The Period Ended March 31, 2023

As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 1, 2022 to March 31, 2023 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited (CIN No. U67190MH1999PTC118368) , which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000004058 having its registered office at C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West) Mumbai MH 400083 IN.
07-04-2023
Bigul

Neogen Chemicals Ltd - 542665 - Closure of Trading Window

This is to inform you that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and the Company''s Code for Prevention of Insider Trading ("Insider Trading Policy"), the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons, connected persons and legitimate insiders of the Company from Saturday, April 1, 2023 till the end of 48 hours after the declaration of audited financial results of the Company for the quarter and financial year ended March 31, 2023. The date of Board Meeting of the Company for consideration and approval of the audited financial results of the Company for the quarter and financial year ended March 31, 2023 will be informed in due course.
31-03-2023
Bigul

Neogen Chemicals Ltd - 542665 - Update On Earlier Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 With Respect To Incorporation Of Wholly Owned Subsidiary Of Neogen Chemicals Limited

Further to the captioned subject and referred letter, we wish to inform that the Company has incorporated the Wholly Owned Subsidiary named 'Neogen Ionics Limited' ('Neogen Ionics') on March 29, 2023. The details required under regulation 30 of SEBI Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD /4/2015 dated September 9, 2015 are as given in the attached disclosure.
30-03-2023
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation

With reference to the captioned subject, please find enclosed herewith the Earnings Presentation on Acquisition of 100% stake in BuLi Chemicals India Private Limited.
08-03-2023

Neogen Chemcials surges nearly 4% on plans to acquire BuLi Chemicals

The total turnover of BuLi Chemicals for FY22 was INR 65.27 crore, up 43.8% from FY21.
06-03-2023
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

With reference to the captioned subject, please find enclosed herewith the Press Release titled 'Neogen Chemicals enters into a definitive agreement to acquire 100% stake in BuLi Chemicals India Pvt. Ltd. from Livent'.
04-03-2023
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Acquisition

With regards to the captioned subject and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors of Neogen Chemicals Limited ('the Company') at its meeting held today i.e. Saturday, March 4, 2023 which commenced at 7.15 p.m. (IST) and concluded at 8.50 p.m.(IST), inter alia, considered and approved, the acquisition of 4,69,26,000 (100%) Equity Shares of a face value of Rs. 10 each, of BuLi Chemicals India Private Limited ('BuLi Chem') for an amount up to Rs. 25,00,00,000 (Twenty-Five Crore) approximately, subject to final working capital adjustments on closing date ('Acquisition')
04-03-2023
Next Page
Close

Let's Open Free Demat Account